IBD Today & Tomorrow 2017
Date: 22 – 23 June 2017
Place: Amsterdam, The Netherlands
3rd IBD Today & Tomorrow Congress
- info@buhlmannlabs.ch
- +41 61 487 12 12
Find detailed descriptions of all our innovative product lines. From our calprotectin assays to our peripheral neuropathy assays to our allergy tests. 
Get to know our product support team, browse through our product specific frequently asked questions and contact us for specific inquiries.
Read the success stories our customer experience with our products in their daily routine diagnostic work and research activities.
New BÜHLMANN CAST® Allergens available! - We are pleased to announce the new 9 BÜHLMANN CAST® Allergens that will reinforce our commitment in the allergy diagnosis. With this release we will strengthen our Hymenoptera venom portfolio with a new dedicated allergen for the European paper wasp, as well as we developed alpha-GAL, a highly standardized allergen to address the new recognized
IBDoc News from ECCO 2017 - IBDoc® has now been on the market for over 2 years and it is transforming the way IBD patients manage their disease. IBDoc® is used by over a thousand patients in more than 15 countries and we now support 20 languages with Hebrew as the latest addition. BÜHLMANN as the only calprotectin company has been able
Neuroimmunology explained in one simple Flyer - Sensitive Screening for anti-neural antibodies is a key step to identify autoimmune peripheral neuropathies. The new Neuroimmunology flyer explains why BÜHLMANN GanglioCombiTM MAG ELISA is the most sensitive screening for anti-Ganglioside and -MAG antibodies in one single step and why anti-MAG antibody ELISA is the gold standard. Click here to get access to the new
Social Links